Biogenesis of Weibel-Palade bodies in von Willebrand’s disease variants with impaired von Willebrand factor intrachain or interchain disulfide bond formation
暂无分享,去创建一个
P. Reitsma | J. Voorberg | K. Valentijn | J. Eikenboom | R. Dirven | Jiong-Wei Wang | D. Groeneveld | G. Cosemans
[1] T. Walz,et al. A pH‐regulated dimeric bouquet in the structure of von Willebrand factor , 2011, The EMBO journal.
[2] T. Springer,et al. Biology and physics of von Willebrand factor concatamers , 2011, Journal of thrombosis and haemostasis : JTH.
[3] P. Reitsma,et al. Intracellular Storage and Regulated Secretion of Von Willebrand Factor in Quantitative Von Willebrand Disease* , 2011, The Journal of Biological Chemistry.
[4] J. Sadler,et al. Phylogenetic and Functional Analysis of Histidine Residues Essential for pH-dependent Multimerization of von Willebrand Factor*♦ , 2011, The Journal of Biological Chemistry.
[5] J. Voorberg,et al. Functional architecture of Weibel-Palade bodies. , 2011, Blood.
[6] R. Schneppenheim,et al. A cluster of mutations in the D3 domain of von Willebrand factor correlates with a distinct subgroup of von Willebrand disease: type 2A/IIE. , 2010, Blood.
[7] P. Rosenthal,et al. Structural organization of Weibel-Palade bodies revealed by cryo-EM of vitrified endothelial cells , 2009, Proceedings of the National Academy of Sciences.
[8] J. Goudemand,et al. Expression of 14 von Willebrand factor mutations identified in patients with type 1 von Willebrand disease from the MCMDM‐1VWD study , 2009, Journal of Thrombosis and Haemostasis.
[9] L. Hewlett,et al. Basal secretion of von Willebrand factor from human endothelial cells. , 2008, Blood.
[10] J. Goudemand,et al. Detailed von Willebrand factor multimer analysis in patients with von Willebrand disease in the European study, molecular and clinical markers for the diagnosis and management of type 1 von Willebrand disease (MCMDM‐1VWD) , 2008, Journal of thrombosis and haemostasis : JTH.
[11] A. Tosetto,et al. Response to desmopressin is influenced by the genotype and phenotype in type 1 von Willebrand disease (VWD): results from the European Study MCMDM-1VWD. , 2008, Blood.
[12] A. Koster,et al. A new look at Weibel-Palade body structure in endothelial cells using electron tomography. , 2008, Journal of structural biology.
[13] E. Egelman,et al. Assembly of Weibel–Palade body-like tubules from N-terminal domains of von Willebrand factor , 2008, Proceedings of the National Academy of Sciences.
[14] Luke T. Dang,et al. Two Cys residues essential for von Willebrand factor multimer assembly in the Golgi , 2007, Proceedings of the National Academy of Sciences.
[15] J. Voorberg,et al. Differential effects of the loss of intrachain- versus interchain-disulfide bonds in the cystine-knot domain of von Willebrand factor on the clinical phenotype of von Willebrand disease , 2006, Thrombosis and Haemostasis.
[16] R. Bertina,et al. Homozygous C2362F von Willebrand factor induces intracellular retention of mutant von Willebrand factor resulting in autosomal recessive severe von Willebrand disease , 2006, British journal of haematology.
[17] É. Fressinaud,et al. Mutations C1157F and C1234W of von Willebrand factor cause intracellular retention with defective multimerization and secretion , 2006, Journal of thrombosis and haemostasis : JTH.
[18] P. Lenting,et al. Cysteine‐mutations in von Willebrand factor associated with increased clearance , 2005, Journal of thrombosis and haemostasis : JTH.
[19] R. Bertina,et al. Dimerization and multimerization defects of von Willebrand factor due to mutated cysteine residues , 2004, Journal of thrombosis and haemostasis : JTH.
[20] D. Cutler,et al. Analysis of intracellular storage and regulated secretion of 3 von Willebrand disease-causing variants of von Willebrand factor. , 2003, Blood.
[21] M. Rondaij,et al. Real-Time Imaging of the Dynamics and Secretory Behavior of Weibel-Palade Bodies , 2003, Arteriosclerosis, thrombosis, and vascular biology.
[22] J. Eikenboom,et al. Type 1 von Willebrand disease mutation Cys1149Arg causes intracellular retention and degradation of heterodimers: a possible general mechanism for dominant mutations of oligomeric proteins. , 2001, Blood.
[23] K. Pasi,et al. Aberrant dimerization of von Willebrand factor as the result of mutations in the carboxy-terminal region: identification of 3 mutations in members of 3 different families with type 2A (phenotype IID) von Willebrand disease. , 2001, Blood.
[24] A. Goodeve,et al. Endoplasmic reticulum retention and prolonged association of a von Willebrand's disease-causing von Willebrand factor variant with ERp57 and calnexin. , 2001, Biochemical and biophysical research communications.
[25] I. Braakman,et al. The CXXCXXC motif determines the folding, structure and stability of human Ero1‐Lα , 2000, The EMBO journal.
[26] J. Sadler,et al. Localization of Disulfide Bonds in the Cystine Knot Domain of Human von Willebrand Factor* , 2000, The Journal of Biological Chemistry.
[27] R. Bertina,et al. Characterization of the Genetic Defects in Recessive Type 1 and Type 3 von Willebrand Disease Patients of Italian Origin , 1998, Thrombosis and Haemostasis.
[28] R. Angeletti,et al. Localization of Endogenous Furin in Cultured Cell Lines , 1997, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.
[29] P. Reitsma,et al. Dominant type 1 von Willebrand disease caused by mutated cysteine residues in the D3 domain of von Willebrand factor. , 1996, Blood.
[30] J. Ware,et al. Defective dimerization of von Willebrand factor subunits due to a Cys-> Arg mutation in type IID von Willebrand disease. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[31] I. Rabinowitz,et al. New variant of von Willebrand disease type II with markedly increased levels of von Willebrand factor antigen and dominant mode of inheritance: von Willebrand disease type IIC Miami. , 1993, Blood.
[32] J. V. van Mourik,et al. Assembly and routing of von Willebrand factor variants: the requirements for disulfide-linked dimerization reside within the carboxy-terminal 151 amino acids , 1991, The Journal of cell biology.
[33] A. Brake,et al. Expression of a human proprotein processing enzyme: correct cleavage of the von Willebrand factor precursor at a paired basic amino acid site. , 1990, Proceedings of the National Academy of Sciences of the United States of America.
[34] R. Siezen,et al. Furin is a subtilisin-like proprotein processing enzyme in higher eukaryotes , 1990, Molecular Biology Reports.
[35] K. Titani,et al. Identification of disulfide-bridged substructures within human von Willebrand factor. , 1987, Biochemistry.
[36] D. Wagner,et al. Inducible secretion of large, biologically potent von Willebrand factor multimers , 1986, Cell.
[37] J. Goudemand,et al. Phenotype and genotype of a cohort of families historically diagnosed with type 1 von Willebrand disease in the European study, Molecular and Clinical Markers for the Diagnosis and Management of Type 1 von Willebrand Disease (MCMDM-1VWD). , 2007, Blood.
[38] Sandra L Haberichter,et al. Re-establishment of VWF-dependent Weibel-Palade bodies in VWD endothelial cells. , 2005, Blood.
[39] F. Cohen,et al. Biochemistry and genetics of von Willebrand factor. , 1998, Annual review of biochemistry.
[40] D. Wagner. Cell biology of von Willebrand factor. , 1990, Annual review of cell biology.